Header Logo

Connection

JEFFREY L JORGENSEN to Clinical Trials as Topic

Back to Details
This is a "connection" page, showing publications JEFFREY L JORGENSEN has written about Clinical Trials as Topic.
JEFFREY L JORGENSEN
Connection Strength
0.019
Clinical Trials as Topic
  1. Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party. Blood. 2018 03 22; 131(12):1275-1291.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.